These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2509491)

  • 41. Progression of childhood linear scleroderma to fatal systemic sclerosis.
    Mayorquin FJ; McCurley TL; Levernier JE; Myers LK; Becker JA; Graham TP; Pincus T
    J Rheumatol; 1994 Oct; 21(10):1955-7. PubMed ID: 7837166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Current findings in progressive systemic sclerosis].
    Zanussi C; Ortolani C; Pastorello E; Riboldi PS; Sabbadini MG
    Minerva Med; 1982 Apr; 73(18):1189-200. PubMed ID: 7043320
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anticentromere antibodies and other antinuclear antibodies in progressive systemic sclerosis].
    Rojas C; Silva MC; Pérez L; Ruiz F
    Rev Med Chil; 1985 May; 113(5):409-14. PubMed ID: 3912881
    [No Abstract]   [Full Text] [Related]  

  • 44. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Digital gangrene in a heavy smoker.
    Kwan LW; Weiner SR; Weisbart R
    Hosp Pract (Off Ed); 1984 Oct; 19(10):261-2. PubMed ID: 6434560
    [No Abstract]   [Full Text] [Related]  

  • 46. [Myositis disclosing systemic scleroderma].
    Leys D; Hatron PY; Parent M; Pasquier F; Krivosic I; Petit H
    Rev Neurol (Paris); 1984; 140(11):670-2. PubMed ID: 6505497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [What is your diagnosis? Scleroderma type II].
    Michaud M
    J Dent Que; 1987 Oct; 24():503-5. PubMed ID: 3482659
    [No Abstract]   [Full Text] [Related]  

  • 48. Nail fold capillaroscopy--a useful aid in the diagnosis of collagen vascular diseases.
    Ross JB
    J Invest Dermatol; 1966 Oct; 47(4):282-5. PubMed ID: 5954159
    [No Abstract]   [Full Text] [Related]  

  • 49. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Characteristics of the clinical course of systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1984 Sep; (9):88-92. PubMed ID: 6506654
    [No Abstract]   [Full Text] [Related]  

  • 51. [Stroke and scleroderma. Cerebral Raynaud?].
    Montaner J; Domínguez J; Molina C; Alvarez-Sabín J
    Neurologia; 2001 May; 16(5):236-7. PubMed ID: 11412726
    [No Abstract]   [Full Text] [Related]  

  • 52. Relationship between nailfold capillary microscopy and salivary capillary basement membrane width in Raynaud's disease and progressive systemic sclerosis.
    DeBure C; Fiessinger JN; Priollet P; Camilleri JP; Vayssairat M; Kazandjian S; Housset E
    J Rheumatol; 1985 Apr; 12(2):279-82. PubMed ID: 4032402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Isolated Raynaud's phenomenon--a benign disorder.
    Sheiner NM; Small P
    Ann Allergy; 1987 Feb; 58(2):114-7. PubMed ID: 3492946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Electron-plethysmographic study of changes of arteriolo-capillary circulation in scleroderma and other collagen diseases].
    Pitea P; Iancu A; Maier N
    Stud Cercet Med Interna; 1972; 13(2):159-66. PubMed ID: 5069963
    [No Abstract]   [Full Text] [Related]  

  • 56. [Homolateral dimelic scleroderma with sclerolichen].
    Galle R; Civatte J; Blanchet P; Benveniste M; Degos R
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):206-7. PubMed ID: 4539351
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?
    Cutolo M; Sulli A; Smith V
    Expert Rev Clin Immunol; 2011 Jul; 7(4):395-7. PubMed ID: 21790279
    [No Abstract]   [Full Text] [Related]  

  • 58. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
    Sheon RP; Kirsner AB
    Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
    [No Abstract]   [Full Text] [Related]  

  • 59. [Diagnostic difficulties in a case of systemic connective tissue disease in a 10-year-old boy].
    Wilkoszewski E; Maldyk E; Wesolowska H; Bernhardt E
    Reumatologia; 1971; 9(4):399-406. PubMed ID: 5316472
    [No Abstract]   [Full Text] [Related]  

  • 60. [Scleroderma. Nosology and classification].
    Fiessinger JN; Housset E
    Rev Prat; 1975 May; 25(25):1925-6, 1929-30, 1933. PubMed ID: 1135582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.